<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="it">
		<id>https://wikifarmaco.org/index.php?action=history&amp;feed=atom&amp;title=Scopolamina-N-butilbromuro</id>
		<title>Scopolamina-N-butilbromuro - Cronologia</title>
		<link rel="self" type="application/atom+xml" href="https://wikifarmaco.org/index.php?action=history&amp;feed=atom&amp;title=Scopolamina-N-butilbromuro"/>
		<link rel="alternate" type="text/html" href="https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;action=history"/>
		<updated>2026-04-16T12:36:27Z</updated>
		<subtitle>Cronologia della pagina su questo sito</subtitle>
		<generator>MediaWiki 1.30.2</generator>

	<entry>
		<id>https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;diff=51784&amp;oldid=prev</id>
		<title>Hadihajar: Sostituzione testo - '|titlemode= append' con '|titlemode='</title>
		<link rel="alternate" type="text/html" href="https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;diff=51784&amp;oldid=prev"/>
				<updated>2014-08-26T20:20:10Z</updated>
		
		<summary type="html">&lt;p&gt;Sostituzione testo - &amp;#039;|titlemode= append&amp;#039; con &amp;#039;|titlemode=&amp;#039;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr style=&quot;vertical-align: top;&quot; lang=&quot;it&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Versione meno recente&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Versione delle 20:20, 26 ago 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot; &gt;Riga 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Riga 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Avvertenze}}{{#seo:&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{Avvertenze}}{{#seo:&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|title= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|title= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|titlemode= &lt;del class=&quot;diffchange diffchange-inline&quot;&gt;append&lt;/del&gt;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|titlemode=&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|keywords= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|keywords= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|description= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|description= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:48289:newid:51784 --&gt;
&lt;/table&gt;</summary>
		<author><name>Hadihajar</name></author>	</entry>

	<entry>
		<id>https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;diff=48289&amp;oldid=prev</id>
		<title>Hadihajar: /* STRUTTURA */</title>
		<link rel="alternate" type="text/html" href="https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;diff=48289&amp;oldid=prev"/>
				<updated>2014-05-20T23:09:31Z</updated>
		
		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;STRUTTURA&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr style=&quot;vertical-align: top;&quot; lang=&quot;it&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Versione meno recente&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Versione delle 23:09, 20 mag 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l17&quot; &gt;Riga 17:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Riga 17:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== STRUTTURA ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== STRUTTURA ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;scopolamina&lt;/del&gt;.jpg&lt;del class=&quot;diffchange diffchange-inline&quot;&gt;|200px&lt;/del&gt;]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[File:&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Scopolamina-N-butilbromuro&lt;/ins&gt;.jpg]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== MECCANISMO D’AZIONE==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== MECCANISMO D’AZIONE==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Hadihajar</name></author>	</entry>

	<entry>
		<id>https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;diff=48283&amp;oldid=prev</id>
		<title>Hadihajar: /* LINK CORRELATI */</title>
		<link rel="alternate" type="text/html" href="https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;diff=48283&amp;oldid=prev"/>
				<updated>2014-05-20T22:53:08Z</updated>
		
		<summary type="html">&lt;p&gt;‎&lt;span dir=&quot;auto&quot;&gt;&lt;span class=&quot;autocomment&quot;&gt;LINK CORRELATI&lt;/span&gt;&lt;/span&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr style=&quot;vertical-align: top;&quot; lang=&quot;it&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Versione meno recente&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Versione delle 22:53, 20 mag 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l85&quot; &gt;Riga 85:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Riga 85:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Categoria:Antimuscarinici spasmolitici]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Categoria:Antimuscarinici spasmolitici]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Categoria:Spasmolitici]]&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;[[Categoria:Spasmolitici]]&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot;&gt;&amp;#160;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{Parasimpaticolitici}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:48256:newid:48283 --&gt;
&lt;/table&gt;</summary>
		<author><name>Hadihajar</name></author>	</entry>

	<entry>
		<id>https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;diff=48256&amp;oldid=prev</id>
		<title>Hadihajar il 21:32, 20 mag 2014</title>
		<link rel="alternate" type="text/html" href="https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;diff=48256&amp;oldid=prev"/>
				<updated>2014-05-20T21:32:06Z</updated>
		
		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table class=&quot;diff diff-contentalign-left&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr style=&quot;vertical-align: top;&quot; lang=&quot;it&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;← Versione meno recente&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: white; color:black; text-align: center;&quot;&gt;Versione delle 21:32, 20 mag 2014&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l5&quot; &gt;Riga 5:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Riga 5:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|description= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;|description= &amp;#160;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;−&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{categorytreeall| |mode=all|onlyroot=on |depth=}}&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;+&lt;/td&gt;&lt;td style=&quot;color:black; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;{{categorytreeall|&lt;ins class=&quot;diffchange diffchange-inline&quot;&gt;Spasmolitici &lt;/ins&gt;|mode=all|onlyroot=on |depth=}}&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== SPECIALITÀ ==&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== SPECIALITÀ ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;'''SCOPOLAMINA BUTILBROMURO'''&lt;/div&gt;&lt;/td&gt;&lt;td class='diff-marker'&gt;&amp;#160;&lt;/td&gt;&lt;td style=&quot;background-color: #f9f9f9; color: #333333; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #e6e6e6; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;'''SCOPOLAMINA BUTILBROMURO'''&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;

&lt;!-- diff cache key wikifarmaco_db_5-mw_:diff:version:1.11a:oldid:48255:newid:48256 --&gt;
&lt;/table&gt;</summary>
		<author><name>Hadihajar</name></author>	</entry>

	<entry>
		<id>https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;diff=48255&amp;oldid=prev</id>
		<title>Hadihajar: Creata pagina con '{{Avvertenze}}{{#seo: |title=  |titlemode= append |keywords=  |description=  }} {{categorytreeall| |mode=all|onlyroot=on |depth=}} == SPECIALITÀ == '''SCOPOLAMINA BUTILBROMUR...'</title>
		<link rel="alternate" type="text/html" href="https://wikifarmaco.org/index.php?title=Scopolamina-N-butilbromuro&amp;diff=48255&amp;oldid=prev"/>
				<updated>2014-05-20T21:30:51Z</updated>
		
		<summary type="html">&lt;p&gt;Creata pagina con &amp;#039;{{Avvertenze}}{{#seo: |title=  |titlemode= append |keywords=  |description=  }} {{categorytreeall| |mode=all|onlyroot=on |depth=}} == SPECIALITÀ == &amp;#039;&amp;#039;&amp;#039;SCOPOLAMINA BUTILBROMUR...&amp;#039;&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nuova pagina&lt;/b&gt;&lt;/p&gt;&lt;div&gt;{{Avvertenze}}{{#seo:&lt;br /&gt;
|title= &lt;br /&gt;
|titlemode= append&lt;br /&gt;
|keywords= &lt;br /&gt;
|description= &lt;br /&gt;
}}&lt;br /&gt;
{{categorytreeall| |mode=all|onlyroot=on |depth=}}&lt;br /&gt;
== SPECIALITÀ ==&lt;br /&gt;
'''SCOPOLAMINA BUTILBROMURO'''&lt;br /&gt;
*'''Buscopan'''&lt;br /&gt;
**'''[[Buscopan|30 COMPRESSE RIVESTITE 10MG]], [[Buscopan|6 SUPPOSTE 10MG]]'''&lt;br /&gt;
**'''[[Buscopan fiale|INTRAMUSCOLO IV 6 FIALE 1ML 20MG]]''' &lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
'''SCOPOLAMINA BUTILBROMURO/[[Paracetamolo|PARACETAMOLO]]:'''&lt;br /&gt;
*'''[[Buscopan compositum]]''' 30 COMPRESSE 10 mg+500 mg, 6 SUPPOSTE 10 mg+800 mg&lt;br /&gt;
&lt;br /&gt;
== STRUTTURA ==&lt;br /&gt;
[[File:scopolamina.jpg|200px]]&lt;br /&gt;
&lt;br /&gt;
== MECCANISMO D’AZIONE==&lt;br /&gt;
'''Scopolamina-N-butilbromuro''' anche nota come '''N-butilbromuro di joscina''' o anche '''butilscopolamina''' è un derivato ammonico quaternario appartenente alla classe degli alcaloidi della belladonna ed è strutturalmente simile al neurotrasmettitore [[acetilcolina]].&lt;br /&gt;
&lt;br /&gt;
Esso è un parasimpaticolitico ed agisce come antagonista competitivo nei confronti dell'acetilcolina sui recettori muscarinici, svolgendo un'azione antispastica sulla muscolatura liscia del tratto gastrointestinale, biliare e genitourinario.&lt;br /&gt;
&lt;br /&gt;
Trattandosi di un derivato ammonico quaternario, alle dosi terapeutiche consigliate, l'N-butilbromuro di joscina non entra nel sistema nervoso centrale e quindi non si manifestano gli effetti indesiderati&lt;br /&gt;
sul SNC dovuti agli anticolinergici. &lt;br /&gt;
&lt;br /&gt;
== INDICAZIONI ==&lt;br /&gt;
*Trattamento sintomatico delle manifestazioni spastico-dolorose del tratto gastroenterico e genito-urinario.&lt;br /&gt;
&lt;br /&gt;
==CONTROINDICAZIONI ==&lt;br /&gt;
*Ipersensibilità al principio attivo.&lt;br /&gt;
*Glaucoma ad angolo acuto.&lt;br /&gt;
*Ipertrofia prostatica o altre cause di ritenzione urinaria.&lt;br /&gt;
*Stenosi pilorica ed altre condizioni stenosanti il canale gastroenterico.&lt;br /&gt;
*Ileo paralitico, colite ulcerosa, megacolon.&lt;br /&gt;
*Esofagite da reflusso.&lt;br /&gt;
*Atonia intestinale dell'anziano e dei soggetti debilitati.&lt;br /&gt;
*Miastenia grave.&lt;br /&gt;
*Bambini di età inferiore ai 6 anni.&lt;br /&gt;
&lt;br /&gt;
== POSOLOGIA ==&lt;br /&gt;
*'''Spasmi''': adulti e ragazzi di età superiore ai 14 anni, per via orale, 10-20 mg tre volte al giorno, oppure una supposta da 10 mg tre volte al giorno.  Per iniezione intramuscolare o endovenosa, 20 mg ripetibili se necessario dopo 30 minuti (anche più spesso in endoscopia). Per il '''buscopan compositum''' la posologia è di 1-2 compresse 3 volte al giorno oppure 1 supposta 3-4 volte al giorno.&lt;br /&gt;
&lt;br /&gt;
==AVVERTENZE==&lt;br /&gt;
Gli anticolinergici vanno usati con prudenza negli anziani, nelle tachiaritmie cardiache, nell’ipertensione arteriosa, nell’insufficienza cardiaca congestizia, nell’ipertiroidismo e nei portatori di affezioni epatiche e renali e  nei pazienti predisposti al glaucoma ad angolo chiuso&lt;br /&gt;
==INTERAZIONI==&lt;br /&gt;
&lt;br /&gt;
{| border=&amp;quot;1&amp;quot; cellspacing=&amp;quot;1&amp;quot; cellpadding=&amp;quot;1&amp;quot; style=&amp;quot;width: px;&amp;quot;&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | &lt;br /&gt;
[[Antidepressivi triciclici]] ([[Amitriptilina]], [[Imipramina]], [[Nortriptilina]])&lt;br /&gt;
&lt;br /&gt;
Antidepressivi tetraciclici ([[Mirtazapina]], [[Mianserina]])&lt;br /&gt;
&lt;br /&gt;
[[Antipsicotici]]&lt;br /&gt;
&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | L'effetto anticolinergico può essere accentuato da Scopolamina-N-butilbromuro..&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | [[Antistaminici]]&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | L'effetto anticolinergico può essere accentuato da Scopolamina-N-butilbromuro.&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | [[Amantadina]]&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | L'effetto anticolinergico può essere accentuato da Scopolamina-N-butilbromuro..&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | [[Anticolinergici]]&amp;amp;nbsp;(tipo [[tiotropio]], [[ipratropio]], ecc.)&amp;amp;nbsp;&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | L'effetto anticolinergico può essere accentuato da Scopolamina-N-butilbromuro.&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | Antagonisti della dopamina, come la [[metoclopramide]].&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | Il trattamento concomitante può determinare una riduzione dell'effetto di entrambi i farmaci sul tratto gastro-intestinale.&lt;br /&gt;
|-&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | Beta adrenergici ([[Salbutamolo]],&amp;amp;nbsp;&amp;lt;div&amp;gt;[[Fenoterolo]], [[Salmeterolo]])&amp;lt;/div&amp;gt;&lt;br /&gt;
| style=&amp;quot;text-align: center;&amp;quot; | La tachicardia indotta da questi farmaci può essere accentuata da Scopolamina-N-butilbromuro.&lt;br /&gt;
|}&lt;br /&gt;
&lt;br /&gt;
&lt;br /&gt;
== EFFETTI COLLATERALI ==&lt;br /&gt;
Generalmente rari e di lieve entità: Secchezza delle fauci, stipsi, ritenzione urinaria, disturbi dell’accomodazione visiva, vertigini, sonnolenza, senso di fatica, disturbi cognitivi e allucinazioni in caso di sovradosaggio. &lt;br /&gt;
==LINK CORRELATI==&lt;br /&gt;
*[[parasimpaticolitici]]&lt;br /&gt;
[[Categoria:Principi attivi]] &lt;br /&gt;
[[Categoria:parasimpaticolitici]]&lt;br /&gt;
[[Categoria:Antimuscarinici]]&lt;br /&gt;
[[Categoria:Antimuscarinici spasmolitici]]&lt;br /&gt;
[[Categoria:Spasmolitici]]&lt;/div&gt;</summary>
		<author><name>Hadihajar</name></author>	</entry>

	</feed>